Bonus BioGroup Ltd. (BONS.TA)
ILA 9.1
(0.0%)
ILA 9.1
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -26.39 Million | -28.81 Million | -39.83 Million | -15.74 Million | -13.11 Million | -13.42 Million |
| Net Income | -28.52 Million | -38.7 Million | -90.07 Million | -22.02 Million | -22.24 Million | -18.73 Million |
| Depreciation & Amortization | 2.76 Million | 2.66 Million | 1.47 Million | 1.06 Million | 1.07 Million | 197 Thousand |
| Deferred income taxes | -1.12 Million | 976 Thousand | 24.75 Million | 2.14 Million | 830 Thousand | -2.69 Million |
| Stock-based compensation | 1.44 Million | 7.6 Million | 9.85 Million | 2.08 Million | 4.82 Million | 2.91 Million |
| Change in working capital | -1.32 Million | -1.34 Million | -8.41 Million | 318 Thousand | 2.34 Million | 1.96 Million |
| Other non-cash items | 377 Thousand | -8000.00 | 22.56 Million | 660 Thousand | 57 Thousand | 2.91 Million |
| Investing Cash Flow | -14.25 Million | -6.29 Million | -6.17 Million | -254 Thousand | -187 Thousand | -341 Thousand |
| Investments in PPE | -824 Thousand | -6.38 Million | -5.8 Million | -254 Thousand | -187 Thousand | -341 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -13.43 Million | - | -367 Thousand | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -13.43 Thousand | 96 Thousand | -367.00 | - | - | - |
| Financing Cash Flow | -1.15 Million | 2.13 Million | 113.41 Million | 31.92 Million | 4.91 Million | 19.55 Million |
| Debt repayment | -1155.00 | -1204.00 | -1650.00 | -670.00 | -663.00 | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 3.33 Million | 111.35 Million | 32.59 Million | 5.58 Million | 19.02 Million |
| Other Financing Activities | -1.15 Million | -1.2 Million | 2.06 Million | -670 Thousand | -663 Thousand | 535 Thousand |
| Accounts receivables | 346.00 | 360.00 | -519.00 | -448.00 | 244.00 | 1.47 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.32 Million | -1.34 Million | -8.41 Million | 318.44 Thousand | 2.33 Million | 315 Thousand |
| Cash at beginning of period | 53.62 Million | 79.55 Million | 16.08 Million | 105 Thousand | 8.64 Million | 2.72 Million |
| Cash at end of period | 12.93 Million | 53.62 Million | 79.55 Million | 16.08 Million | 105 Thousand | 8.64 Million |
| Capital Expenditure | -824 Thousand | -6.38 Million | -5.8 Million | -254 Thousand | -187 Thousand | -341 Thousand |
| Effect of forex changes on cash | 1.12 Million | 7.04 Million | -3.93 Million | 60 Thousand | -154 Thousand | 125 Thousand |
| Net cash flow / Change in cash | -40.68 Million | -25.92 Million | 63.46 Million | 15.98 Million | -8.53 Million | 5.91 Million |
| Free Cash Flow | -27.22 Million | -35.2 Million | -45.64 Million | -16 Million | -13.3 Million | -13.76 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.05 Million | -7.92 Million | -7.5 Million | -28.52 Million | -6.7 Million | -6.7 Million |
| Depreciation & Amortization | 695 Thousand | 698 Thousand | 700 Thousand | 2.76 Million | 695 Thousand | 686 Thousand |
| Deferred income taxes | - | - | 19 Thousand | -1.12 Million | -302 Thousand | -394 Thousand |
| Stock-based compensation | 472 Thousand | 596 Thousand | 53 Thousand | 1.44 Million | 376 Thousand | 513 Thousand |
| Change in working capital | -9000.00 | 1.59 Million | 302 Thousand | -1.32 Million | -55 Thousand | -723 Thousand |
| Other non-cash items | 31 Thousand | -1000.00 | 390 Thousand | 377 Thousand | -3000.00 | -5000.00 |
| Investing Cash Flow | 3.77 Million | 8.95 Million | -3.95 Million | -14.25 Million | -9.68 Million | -182 Thousand |
| Investments in PPE | -83 Thousand | -181 Thousand | -100 Thousand | -824 Thousand | -100 Thousand | -182 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -3.85 Million | -13.43 Million | -9.58 Million | - |
| Sales/Maturities of investments | 3.86 Million | 9.13 Million | - | - | - | - |
| Other Investing Activities | - | 9135.00 | -3852.00 | -13.43 Thousand | -9581.00 | - |
| Financing Cash Flow | -314 Thousand | -307 Thousand | -301 Thousand | -1.15 Million | -294 Thousand | -284 Thousand |
| Debt repayment | - | -307.00 | -301.00 | -1155.00 | -294.00 | -284.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -314 Thousand | - | - | - | - | - |
| Accounts receivables | 64 Thousand | -37.00 | -94.00 | 346.00 | 265.00 | 511.00 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -73 Thousand | 732.00 | 302.09 Thousand | -1.32 Million | -55.26 Thousand | -723.51 Thousand |
| Cash at beginning of period | 16.54 Million | 12.93 Million | 23.24 Million | 53.62 Million | 38.91 Million | 45.61 Million |
| Cash at end of period | 14.14 Million | 16.54 Million | 12.93 Million | 12.93 Million | 23.24 Million | 38.91 Million |
| Capital Expenditure | -83 Thousand | -181 Thousand | -100 Thousand | -824 Thousand | -100 Thousand | -182 Thousand |
| Effect of forex changes on cash | 178 Thousand | 38 Thousand | -19 Thousand | 1.12 Million | 302 Thousand | 394 Thousand |
| Net cash flow / Change in cash | -2.4 Million | 3.6 Million | -10.31 Million | -40.68 Million | -15.67 Million | -6.69 Million |
| Free Cash Flow | -6.12 Million | -5.25 Million | -6.13 Million | -27.22 Million | -6.09 Million | -6.8 Million |
SBSI
ORIENTHOT
4706
PLL
7721
1709